SCHEMBL362588

SCHEMBL362588

CC(O)(C(N)=O)c1ccc(F)c(F)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNN4 O15554 11/20 0.56
▸ HDAC3 O15379 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ CES2 O00748 1/20 0.39
▸ CES1 P23141 1/20 0.39
▸ AKR1C3 P42330 1/20 0.39
▸ AKR1C2 P52895 1/20 0.39
▸ CHRNA1 P02708 1/20 0.38
▸ CHRNG P07510 1/20 0.38
▸ CHRNB1 P11230 1/20 0.38
▸ CHRNB2 P17787 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ CHRNB4 P30926 1/20 0.38
▸ CHRNA3 P32297 1/20 0.38
▸ CHRNA4 P43681 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ CHRND Q07001 1/20 0.38
▸ MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21229776 0.83 KCNN4 (0.45) KCNN4HDAC3HDAC1HDAC2HDAC6
SCHEMBL6967423 0.76 KCNN4 (0.43) KCNN4HDAC3HDAC1HDAC2HDAC6
SCHEMBL27902048 0.76 KCNN4 (0.43) KCNN4HDAC3HDAC1HDAC2HDAC6
SCHEMBL363513 0.75 KMT2A (0.56) MAPTKMT2A
SCHEMBL6326377 0.74 CYP1A2 (0.53) KCNN4HDAC3HDAC1HDAC2HDAC6
SCHEMBL6326382 0.74 CYP1A2 (0.53) KCNN4HDAC3HDAC1HDAC2HDAC6
SCHEMBL1627216 0.73 AKR1C3 (0.64) KCNN4HDAC3HDAC1HDAC2HDAC6
SCHEMBL31294792 0.73 KCNN4 (0.46) KCNN4HDAC3HDAC1HDAC2HDAC6
SCHEMBL362789 0.73 CES2 (0.50) CES2MAPTKMT2A
SCHEMBL28091068 0.72 MEN1 (0.41) KCNN4HDAC3HDAC1HDAC2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593424-A1 NOVEL ARYLAMIDE DERIVATIVES HAVING ANTIANDROGENIC PROPERTIES Medeia Therapeutics Ltd (FI) 2013-05-22 — — EP claimed
WO-2012007644-A1 NOVEL ARYLAMIDE DERIVATIVES HAVING ANTIANDROGENIC PROPERTIES MEDEIA THERAPEUTICS LTD (FI) 2012-01-19 — — WO claimed
Send feedback